Analysis of the sensitization spectrum in patients with severe allergic diseases using the ImmunoCAP ISAC method

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: An important advance in modern allergology has been made by the introduction of allergenic molecules/components, including their detection by the ImmunoCAP ISAC method. This method is useful in patients with a complex spectrum of sensitization and severe forms of allergic diseases, where various predictors of severe course are actively searched for.

AIM: To evaluate the informativeness of component resolved diagnostic by ISAC ImmunoCAP method in patients with severe bronchial asthma and severe atopic dermatitis.

MATERIALS AND METHODS: A single-center retrospective study was conducted from January to August 2023. 100 patients who were candidates for biologicals for severe bronchial asthma (group 1; 63 patients), severe atopic dermatitis (group 2; 20 patients), or their combination (group 3; 17 patients) were included. Component restlved diagnostic was performed by ImmunoCAP ISAC method.

RESULTS: Polysensitization and high occurrence of food and fungal allergens were more frequently detected in the groups of patients with severe atopic dermatitis. When analyzing the pollen sensitization spectrum in groups 2 and 3, Bet v 1 and PR-10 family cross-linked molecules (Mal d 1, Pru p 1, Ara h 8, Gly m 4, Cor a 1.04), as well as Ole e 9, Cyn d 1, Ph p 1 and Par j 2 were the most common. Epidermal allergens were common in all three groups. Lipocains (Can f 1, Can f 4, Can f 6, Ecu q 1, Mus m 1), kallikreins (Can f 5), and albumin (Fel d 2) dominated among them. The presence of sensitization to household allergens was detected only in group 2 and only to the molecule Der p 23. Among fungal allergens, the allergen Asp f 6 was predominant in the groups with severe atopic dermatitis, and the component Alt a 1 in patients with severe bronchial asthma. Among food allergens, one of the most common allergens was the molecule Gad c 1, Gal d 1, Gal d 2, Gal d 5 and Bos d 6.

CONCLUSION: Component resolved diagnostic is an accurate assay suitable for determining the spectrum of sensitization in patients; its result can serve as a distinct biomarker for severe allergic diseases.

About the authors

Daria S. Fomina

Moscow City Hospital 52; The First Sechenov Moscow State Medical University (Sechenov University); Astana Medical University

Email: daria_fomina@mail.ru
ORCID iD: 0000-0002-5083-6637

MD, Cand. Sci. (Med.), Associate Professor

Russian Federation, Moscow; Moscow; Astana, Republic of Kazakhstan

Marina S. Lebedkina

Moscow City Hospital 52

Author for correspondence.
Email: marina.ivanova0808@yandex.ru
ORCID iD: 0000-0002-9545-4720
Russian Federation, Moscow

Ekaterina A. Nikitina

Moscow City Hospital 52; The First Sechenov Moscow State Medical University (Sechenov University)

Email: katrin88866@gmail.com
ORCID iD: 0000-0002-0865-8355
Moscow; Moscow

Alexander D. Dushkin

The First Sechenov Moscow State Medical University (Sechenov University); Moscow Cancer Hospital

Email: alex@drdushkin.ru
ORCID iD: 0000-0002-8013-5276

MD, Cand. Sci. (Med.)

Russian Federation, Moscow; Moscow

Anton A. Chernov

Moscow City Hospital 52

Email: sbornaya1med@yandex.ru
ORCID iD: 0000-0001-6209-387X

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Yulia D. Yukhnovskaya

The First Sechenov Moscow State Medical University (Sechenov University)

Email: yukhyuliya@yandex.ru
ORCID iD: 0000-0002-0928-2054
Russian Federation, Moscow

Mariana A. Lysenko

Moscow City Hospital 52; The Russian National Research Medical University named after N.I. Pirogov

Email: gkb52@zdrav.mos.ru
ORCID iD: 0000-0001-6010-7975

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow; Moscow

Alexander V. Karaulov

The First Sechenov Moscow State Medical University (Sechenov University)

Email: drkaraulov@mail.ru
ORCID iD: 0000-0002-1930-5424

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

References

  1. Valenta R, Duchene M, Vrtala S, et al. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J Allergy Clin Immunol. 1991;88(6):889–894. doi: 10.1016/0091-6749(91)90245-j
  2. Van Hage M, Hamsten C, Valenta R. ImmunoCAP assays: Pros and cons in allergology. J Allergy Clin Immunol. 2017;140(4):974–977. doi: 10.1016/j.jaci.2017.05.008
  3. Almeida AL, Perger EL, Gomes RH, et al. Objective evaluation of immediate reading skin prick test applying image planimetric and reaction thermometry analyses. J Immunol Methods. 2020;487:112870. doi: 10.1016/j.jim.2020.112870
  4. Justo X, Díaz I, Gil JJ, Gastaminza G. Prick test: Evolution towards automated reading. Allergy. 2016;71(8):1095–1102. doi: 10.1111/all.12921
  5. Gungor A, Houser SM, Aquino BF, et al. A comparison of skin endpoint titration and skin-prick testing in the diagnosis of allergic rhinitis. Ear Nose Throat J. 2004;83(1):54–60.
  6. Ansotegui IJ, Melioli G, Walter G, et al. Open access a WAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnosis (PAMD): Update 2020. World Allergy Organ J. 2020;13(2):1–46. doi: 10.1016/j.waojou.2019.100091
  7. Vaňková R, Čelakovská J, Bukač J, et al. Sensitization to molecular components in 104 atopic dermatitis patients in relation to subgroups of patients suffering from bronchial asthma and allergic rhinitis. Acta Medica (Hradec Kralove). 2020;63(4):164–175. doi: 10.14712/18059694.2020.59
  8. Čelakovská J, Bukač J, Vaňková R, et al. ISAC multiplex testing-- results of examination in 100 patients suffering from atopic dermatitis. Food and Agricultural Immunology. 2020;31(1):1014–1035. doi: 10.1080/09540105.2020.1799947
  9. Wojciechowska M, Żbikowska-Gotz M, Marek-Józefowicz L, et al. Allergic phenotypes in adult patients with atopic dermatitis, determined with the ISAC test (ImmunoCAP ISAC). Postepy Dermatol Alergol. 2018;35(4):351–359. doi: 10.5114/ada.2018.77664
  10. Mittermann I, Wikberg G, Johansson C, et al. IgE sensitizetion profiles differ between adult patients with severe and moderate atopic dermatitis. Plos One. 2016;11(5):e0156077. doi: 10.1371/journal.pone.0156077
  11. GINA. Global strategy for asthma management and prevention. Updated May 2023. 246 p. Available from: https://ginasthma.org/wp-content/uploads/2023/05/GINA-2023-Full-Report-2023-WMS.pdf. Accessed: 20.01.2024.
  12. Kubanov AA, Namazova-Baranova LS, Khaitov RM, et al. Atopic dermatitis. Russ J Allergy. 2021;18(3):44–92. doi: 10.36691/RJA1474
  13. Talaminos Barroso A, Márquez Martín E, Roa Romero LM, Ortega Ruiz F. Factors affecting lung function: A review of the literature. Arch Bronconeumol (Engl Ed). 2018;54(6):327–332. doi: 10.1016/j.arbres.2018.01.030
  14. Laidlaw TM, Mullol J, Woessner KM, et al. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract. 2021;9(3):1133–1141. doi: 10.1016/j.jaip.2020.09.063
  15. Kiiski V, Karlsson O, Remitz A, Reitamo S. High serum total IgE predicts poor long-term outcome in atopic dermatitis. Acta Derm Venereol. 2015;95(8):943–947. doi: 10.2340/00015555-2126
  16. Trzeciak M, Glen J, Bandurski T, et al. Relationship between serum levels of interleukin-18, IgE and disease severity in patients with atopic dermatitis. Clin Exp Dermatol. 2011;36(7):728–732. doi: 10.1111/j.1365-2230.2011.04113.x
  17. Kaminishi K, Soma Y, Kawa Y, Mizoguchi M. Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci. 2002;29(1):19–25. doi: 10.1016/s0923-1811(01)00174-8
  18. Emons JA, Gerth van Wijk R. Food allergy and asthma: Is there a link? Curr Treat Options Allergy. 2018;5(4):436–444. doi: 10.1007/s40521-018-0185-1
  19. Konradsen JR, Nordlund B, Onell A, et al. Severe childhood asthma and allergy to furry animals: Refined assessment using molecular-based allergy diagnostics. Pediatr Allergy Immunol. 2014;25(2):187–192. doi: 10.1111/pai.12198
  20. Nordlund B, Konradsen JR, Kull I, et al. IgE antibodies to animal-derived lipocalin, kallikrein and secretoglobin are markers of bronchial inflammation in severe childhood asthma. Allergy. 2012;67(5):661–669. doi: 10.1111/j.1398-9995.2012.02797.x
  21. Korpi A, Mäntyjärvi R, Rautiainen J, et al. Detection of mouse and rat urinary aeroallergens with an improved ELISA. J Allergy Clin Immunol. 2004;113(4):677–682. doi: 10.1016/j.jaci.2003.11.039
  22. Čelakovská J, Ettlerová K, Ettler K, et al. Sensitization to aeroallergens in atopic dermatitis patients: Association with concomitant allergic diseases. J Eur Acad Dermatol Venereol. 2015;29(8):1500–1505. doi: 10.1111/jdv.12891
  23. Nwaru BI, Suzuki S, Ekerljung L, et al. Furry animal allergen component sensitization and clinical outcomes in adult asthma and rhinitis. J Allergy Clin Immunol Pract. 2019;7(4):1230–1238.e4. doi: 10.1016/j.jaip.2018.12.018
  24. Pónyai G, Hidvégi B, Németh I, et al. Contact and aeroallergens in adulthood atopic dermatitis. J Eur Acad Dermatol Venerol. 2008;22(11):1346–1355. doi: 10.1111/j.1468-3083.2008.02886.x
  25. Weghofer M, Grote M, Resch Y, et al. Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol. 2013;190:3059–3067. doi: 10.4049/jimmunol.1202288
  26. Calderón MA, Linneberg A, Kleine-Tebbe J, et al. Respiratory allergy caused by house dust mites: What do we really know? J Allergy Clin Immunol. 2015;136(1):38–48. doi: 10.1016/j.jaci.2014.10.012
  27. Mertens J, Wellbrock M, Feidert F. [Correlation between nasal polyposis and perennial allergy exemplified by house dust mite and house dust allergy. (In German)]. HNO. 1991;39(8):307–310.
  28. Kallawicha K, Chuang YC, Lung SC, et al. Exposure to ambient bioaerosols is associated with allergic skin diseases in Greater Taipei residents. Environ Pollut. 2016;216:845–850. doi: 10.1016/j.envpol.2016.06.057
  29. Gaitanis G, Magiatis P, Hantschke M, et al. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25(1):106–141. doi: 10.1128/CMR.00021-11
  30. Saaf AM, Tengvall-Linder M, Chang HY, et al. Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes. PLoS One. 2008;3(12):e4017. doi: 10.1371/journal.pone.0004017
  31. Muthu V, Sehgal IS, Dhooria S, et al. Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: A systematic review and diagnostic test accuracy meta-analysis. Clin Exp Allergy. 2018;48:1107–1136. doi: 10.1111/cea.13216
  32. Twaroch TE, Curin M, Valenta R, et al. Mold allergens in respiratory allergy: From structure to therapy. Allergy Asthma Immunol Res. 2015;7:205–220. doi: 10.4168/aair.2015.7.3.205
  33. Caraballo L, Valenta R, Puerta L, et al. The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources. World Allergy Organ J. 2020;13:100118. doi: 10.1016/j.waojou.2020.100118
  34. Ando H, Movérare R, Kondo Y, et al. Utility of ovomucoid-specific IgE concentrations in predicting symptomatic egg allergy. J Allergy Clin Immunol. 2008;122(3):583–588. doi: 10.1016/j.jaci.2008.06.016
  35. Ott H, Fölster-Holst R, Merk HF, Baron JM. Allergen microarrays: A novel tool for high-resolution IgE profiling in adults with atopic dermatitis. Eur J Dermatol. 2010;20(1):54–61. doi: 10.1684/ejd.2010.0810
  36. Fomina DS, Mukhina OA, Lebedkina MS, et al. Registry analysis of patients with severe allergic asthma and clinically significant sensitisation to fungal allergens treated with genetically engineered biological drugs. Consilium Medicum. 2022;24(3):170–176. doi: 10.26442/20751753.2022.3.201442
  37. Fung I, Kim JS, Spergel JM. Relating microarray component testing and reported food allergy and food-triggered atopic dermatitis: A real-world analysis. Ann Allergy Asthma Immunol. 2013;110(3):173–177.e1. doi: 10.1016/j.anai.2012.12.006
  38. Iweala OI, Choudhary SK, Commins SP. Food allergy. Curr Gastroenterol Rep. 2018;20(5):17. doi: 10.1007/s11894-018-0624-y
  39. Warren CM, Jiang J, Gupta RS. Epidemiology and burden of food allergy. Curr Allergy Asthma Rep. 2020;20(2):6. doi: 10.1007/s11882-020-0898-7
  40. Pascual CY, Reche M, Fiandor A, et al. Fish allergy in childhood. Pediatr Allergy Immunol. 2008;19(7):573–579. doi: 10.1111/j.1399-3038.2008.00822.x
  41. Benhamou Senouf AH, Borres MP, Eigenmann PA. Native and denatured egg white protein IgE tests discriminate hen‘s egg allergic from egg-tolerant children. Pediatr Allergy Immunol. 2015;26(1):12–17. doi: 10.1111/ pai.12317
  42. Röckmann H, van Geel MJ, Knulst AC, et al. Food allergen sensitization pattern in adults in relation to severity of atopic dermatitis. Clin Transl Allergy. 2014;4(1):9. doi: 10.1186/2045-7022-4-9

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Prevalence of sensitization to pollen allergy components in each group. Note. тАтД ― severe atopic dermatitis; тБА ― severe bronchial asthma.

Download (212KB)
3. Fig. 2. Prevalence of sensitization to epidermal allergy components in each group. Note. тАтД ― severe atopic dermatitis; тБА ― severe bronchial asthma.

Download (174KB)
4. Fig. 3. Prevalence of sensitization to food allergy components in each group. Note. тАтД ― severe atopic dermatitis; тБА ― severe bronchial asthma.

Download (205KB)
5. Fig. 4. Level of significance of allergy components from the ISAC ImmunoCAP panel.

Download (130KB)
6. Fig. 5. Prevalence of molecules in the group of patients with a combination of allergic rhinoconjunctivitis, bronchial asthma and atopic dermatitis.

Download (245KB)
7. Fig. 6. Level of significance of allergic components from the ISAC panel in patients with a combination of allergic rhinoconjunctivitis, bronchial asthma and atopic dermatitis.

Download (112KB)
8. Fig. 7. Correlation analysis of clinical and epidemiologic data in group 1. Note. тБА ― severe bronchial asthma; БА ― bronchial asthma; ОФВ1 ― forced expiratory volume in 1 second; ИМТ ― body mass index; ГЭРБ ― gastroesophageal reflux disease; ХОБЛ ― chronic obstructive pulmonary disease; АРК ― allergic rhinoconjunctivitis; ХПРС ― chronic polyposis rhinosinusitis; ХСК ― chronic spontaneous urticaria; ХИК ― chronic induced urticaria; ИПА/ППА ― true/cross food allergy; Комбо АтД ― comorbid atopic dermatitis; Неперенос НПВС ― intolerance to non-steroidal anti-inflammatory drugs; БытА ― household allergens; ЭА ― epidermal allergens; ГА ― fungal allergens; ПА ― food allergens; ПыльцА ― pollen allergens.

Download (218KB)
9. Fig. 8. Correlation analysis of clinical and epidemiologic data in group 2. Note. тАтД ― severe atopic dermatitis; АД ― atopic dermatitis; БА ― bronchial asthma; ОФВ1 ― forced expiratory volume in 1 second; ИМТ ― body mass index; ГЭРБ ― gastroesophageal reflux disease; ХОБЛ ― chronic obstructive pulmonary disease; АРК ― allergic rhinoconjunctivitis; ХПРС ― chronic polyposis rhinosinusitis; ХСК ― chronic spontaneous urticaria; ХИК ― chronic induced urticaria; ИПА/ППА ― true/cross food allergy; Комбо АтД ― comorbid atopic dermatitis; Неперенос НПВС ― intolerance to non-steroidal anti-inflammatory drugs; БытА ― household allergens; ЭА ― epidermal allergens; ГА ― fungal allergens; ПА ― food allergens; ПыльцА ― pollen allergens.

Download (165KB)
10. Fig. 9. Correlation analysis of clinical and epidemiologic data in group 3. Note. тАтД ― severe atopic dermatitis; тБА ― severe bronchial asthma; БА ― bronchial asthma; ОФВ1 ― forced expiratory volume in 1 second; ИМТ ― body mass index; ГЭРБ ― gastroesophageal reflux disease; ХОБЛ ― chronic obstructive pulmonary disease; АРК ― allergic rhinoconjunctivitis; ХПРС ― chronic polyposis rhinosinusitis; ХСК ― chronic spontaneous urticaria; ХИК ― chronic induced urticaria; ИПА/ППА ― true/ cross food allergy; Комбо АтД ― comorbid atopic dermatitis; Неперенос НПВС ― intolerance to non-steroidal anti-inflammatory drugs; БытА ― household allergens; ЭА ― epidermal allergens; ГА ― fungal allergens; ПА ― food allergens; ПыльцА ― pollen allergens.

Download (201KB)

Copyright (c) 2024 Pharmarus Print Media

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies